Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effects of concentrate main carbohydrate type on methane emissions, milk production and feeding behavior in grazing late-lactation dairy cows.

Frontiers in veterinary science·2026
Same author

Effects of Colostrum Source, Dose and Processing on <i>In Vitro</i> Rumen Fermentation in Weaned Lambs.

Animals : an open access journal from MDPI·2026
Same author

Ruminal pH Dynamics and Milk Production Response to Concentrate Supplementation in Pasture-Based Dairy Cows.

Animals : an open access journal from MDPI·2026
Same author

Influence of sire fertility on the metabolism of in vitro produced embryos.

Reproduction & fertility·2026
Same author

Associations between subclinical bovine respiratory disease, growth patterns, and the nasal and fecal microbiota in dairy replacement heifers: a retrospective study.

Frontiers in veterinary science·2026
Same author

<i>De novo</i> COVID-19-associated insulin resistance drives dysregulated neutrophil extracellular trap formation (NETosis) four months after infection.

Frontiers in immunology·2026

相关实验视频

Updated: Jun 21, 2026

The Use of an Automated System GreenFeed to Monitor Enteric Methane and Carbon Dioxide Emissions from Ruminant Animals
11:02

The Use of an Automated System GreenFeed to Monitor Enteric Methane and Carbon Dioxide Emissions from Ruminant Animals

Published on: September 7, 2015

21.7K

用于减轻甲的料添加剂:在反动物研究中测试肠道减轻甲的料添加剂的建议.

Alexander N Hristov1, André Bannink2, Marco Battelli3

  • 1Department of Animal Science, The Pennsylvania State University, University Park, PA 16802.

Journal of dairy science
|December 26, 2024
PubMed
概括

对于抗甲基料添加剂 (AMFA) 需要严格的测试标准,以减少反动物的肠道甲排放. 本综述概述了研究设计,数据分析和甲测量的指导方针,以确保可靠的疗效确认.

关键词:
肠道甲缓解缓解的方法料添加剂 料添加剂准则 准则 准则转动物的转动物动物

更多相关视频

Lab-Scale Model to Evaluate Odor and Gas Concentrations Emitted by Deep Bedded Pack Manure
06:52

Lab-Scale Model to Evaluate Odor and Gas Concentrations Emitted by Deep Bedded Pack Manure

Published on: July 19, 2018

6.3K
Author Spotlight: Advancing Anaerobic Microbiota Research Using a Novel Respirometry Protocol
06:11

Author Spotlight: Advancing Anaerobic Microbiota Research Using a Novel Respirometry Protocol

Published on: April 26, 2024

1.1K

相关实验视频

Last Updated: Jun 21, 2026

The Use of an Automated System GreenFeed to Monitor Enteric Methane and Carbon Dioxide Emissions from Ruminant Animals
11:02

The Use of an Automated System GreenFeed to Monitor Enteric Methane and Carbon Dioxide Emissions from Ruminant Animals

Published on: September 7, 2015

21.7K
Lab-Scale Model to Evaluate Odor and Gas Concentrations Emitted by Deep Bedded Pack Manure
06:52

Lab-Scale Model to Evaluate Odor and Gas Concentrations Emitted by Deep Bedded Pack Manure

Published on: July 19, 2018

6.3K
Author Spotlight: Advancing Anaerobic Microbiota Research Using a Novel Respirometry Protocol
06:11

Author Spotlight: Advancing Anaerobic Microbiota Research Using a Novel Respirometry Protocol

Published on: April 26, 2024

1.1K

科学领域:

  • 动物营养与环境科学.
  • 农业技术和可持续性.

背景情况:

  • 来自反动物的肠道甲排放对温室气体有很大贡献.
  • 抗甲基素料添加剂 (AMFA) 是一个有希望的缓解策略.
  • 目前对AMFA的测试标准缺乏科学严谨性和标准化.

研究的目的:

  • 为在反动物中对AMFA进行科学测试提供指导方针.
  • 建立标准来评估料添加剂的抗甲基和生产效应.
  • 为了确保可靠的疗效确认,在提出缓解要求之前.

主要方法:

  • 关于研究设计的建议,包括假设的制定和统计分析.
  • 评估饮食效应,与其他策略的关联效应以及生产反应的指导方针.
  • 评估适当的甲测量技术 (呼吸室,SF6,GreenFeed) 和生理/健康影响.

主要成果:

  • 提出了评估AMFA有效性和安全性的综合框架.
  • 强调需要长期研究和生产系统的代表性实验.
  • 强调收集和分析生产,健康和产品质量数据的重要性.

结论:

  • 标准化,科学健全的测试对于验证AMFA至关重要.
  • 遵守拟议的指导方针将确保实际和适用的结果.
  • 对AMFA的有效性声明只应在经过严格的动物研究后进行确认.